Blood Research

Cited by CrossRef (9)

  1. So Yeon Jeon, Ho-Young Yhim, Hee Sun Kim, Jeong-A Kim, Deok-Hwan Yang, Jae-Yong Kwak. The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin’s lymphoma who are candidates for up-front autologous stem cell transplantation. Korean J Intern Med 2018;33:1169
    https://doi.org/10.3904/kjim.2016.163
  2. Giovanni Carulli, Virginia Ottaviano, Paola Sammuri, Cristiana Domenichini, Valentina Guerri, Martina Rousseau, Eugenio M. Ciancia, Elena Ciabatti, Mario Petrini. Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study. Int J Hematol 2015;102:59
    https://doi.org/10.1007/s12185-015-1798-9
  3. Na Dai, Yeye Zhou, Shengming Deng, Shibiao Sang, Yiwei Wu, Alexander R. Haug. Prognostic Value of 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores. Contrast Media & Molecular Imaging 2021;2021:1
    https://doi.org/10.1155/2021/5510825
  4. Woojung Jeon, Young Kwon Koh, Sunghan Kang, Hyery Kim, Kyung-Nam Koh, Ho Joon Im. Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis. Blood Res 2022;57:41
    https://doi.org/10.5045/br.2021.2021164
  5. Hong Ghi Lee, Sung-Yong Kim, Inho Kim, Yeo-Kyeoung Kim, Jeong-A Kim, Yang Soo Kim, Ho Sup Lee, Jinny Park, Seok Jin Kim, Hyeok Shim, Hyeon Seok Eom, Byeong-Bae Park, Junglim Lee, Sung Kyu Park, June-Won Cheong, Keon Woo Park. Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation. Blood Res 2015;50:160
    https://doi.org/10.5045/br.2015.50.3.160
  6. Manzar Alam, Sabeeha Ali, Taj Mohammad, Gulam Mustafa Hasan, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan. B Cell Lymphoma 2: A Potential Therapeutic Target for Cancer Therapy. IJMS 2021;22:10442
    https://doi.org/10.3390/ijms221910442
  7. Chen Wang, Panli Li, Shan Wu, Jianda Lu, Qiufang Liu, Huajie Luo, Shaoli Song. The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma. 2016;37:338
    https://doi.org/10.1097/MNM.0000000000000468
  8. Hugo J. A. Adams, Thomas C. Kwee. Pretransplant FDG‐PET in aggressive non‐Hodgkin lymphoma: systematic review and meta‐analysis. European J of Haematology 2017;98:337
    https://doi.org/10.1111/ejh.12837
  9. Yu Ri Kim, Soo-Jeong Kim, June-Won Cheong, Deok-Hwan Yang, Hyewon Lee, Hyeon-Seok Eom, Yong Oh Sung, Hyo Jung Kim, Hye Jin Kang, Won-Sik Lee, Yong Park, Woo-Ick Yang, Yoo Hong Min, Jin Seok Kim. The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase. Ann Hematol 2016;95:1491
    https://doi.org/10.1007/s00277-016-2729-4
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd